Pharmacokinetic Evaluation of a Single Intramuscular High Dose versus an Oral Long-Term Supplementation of Cholecalciferol
Autor: | Gennadiy Drozdenko, Margitta Worm, Alexander Krannich, Sabine Dölle, Guido Heine, K. Wylon |
---|---|
Rok vydání: | 2015 |
Předmět: |
Male
lcsh:Medicine Administration Oral Organic chemistry 600 Technik Medizin angewandte Wissenschaften::610 Medizin und Gesundheit Placebo group Cohort Studies chemistry.chemical_compound 0302 clinical medicine Elderly Oral administration 030212 general & internal medicine Vitamin D lcsh:Science Routes of Administration Cholecalciferol Multidisciplinary Vitamins Physical sciences Chemistry Nutritional deficiencies Micronutrient Deficiencies Female Intramuscular injection Research Article Adult medicine.medical_specialty 030209 endocrinology & metabolism Injections Intramuscular vitamin D deficiency 03 medical and health sciences Chemical compounds Pharmacokinetics Internal medicine Organic compounds medicine Vitamin D and neurology Humans Intramuscular Injections Nutrition Medicine and health sciences Pharmacology Vitamin D deficiency Biology and life sciences business.industry lcsh:R Vitamin D intake medicine.disease Endocrinology chemistry Geriatrics Age Groups People and Places lcsh:Q Population Groupings business |
Zdroj: | PLoS ONE PLoS ONE, Vol 12, Iss 1, p e0169620 (2017) |
ISSN: | 1932-6203 |
Popis: | Background and Objectives Vitamin D deficiency is frequent during the winter and occurs throughout the year in the elderly or patients suffering from autoimmune diseases. The objective of this study was to evaluate the pharmacokinetic properties of oral supplementation versus a single intramuscular injection of cholecalciferol in healthy individuals. Research design and methods Up to 8,000 I.U. oral cholecalciferol was administered daily for 84 days in a 4 week dose-escalation setting to vitamin D deficient individuals. In another cohort, a single intramuscular injection of 100,000 I.U. cholecalciferol was given. In both cohorts, individuals without vitamin D intake served as the comparison group. 25-hydroxyvitamin D (25(OH)D) concentrations were measured in all individuals at defined time points throughout the studies. Results The mean 25(OH)D serum concentration increased significantly after oral cholecalciferol intake compared to the control group (day 28: 83.4 nmol/l and 42.5 nmol/l; day 56: 127.4 nmol/l and 37.3 nmol/l; day 84: 159.7 nmol/l and 30.0 nmol/l). In individuals receiving 100,000 I.U. cholecalciferol intramuscular, the mean 25(OH)D serum concentration peaked after 4 weeks measuring 70.9 nmol/l compared to 32.7 nmol/l in the placebo group (p = 0.002). The increase of 25(OH)D serum concentrations after 28 days was comparable between both routes of administration (p = 0.264). Conclusions Oral and intramuscular cholecalciferol supplementation effectively increased serum 25(OH)D concentrations. |
Databáze: | OpenAIRE |
Externí odkaz: |